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Aim To assess how ovarian-derived sex hormones (in par-
ticular progesterone) modify the effects of single acute 
stress on the mechanical and biochemical properties of 
left ventricular cardiomyocytes in the rat.
Methods Non-ovariectomized (control, n = 8) and ova-
riectomized (OVX, n = 8) female rats were kept under nor-
mal conditions or were exposed to stress (control-S, n = 8 
and OVX-S, n = 8). Serum progesterone levels were mea-
sured using a chemiluminescent immunoassay. Left ven-
tricular myocardial samples were used for isometric force 
measurements and protein analysis. Ca2+-dependent ac-
tive force (Factive), Ca
2+-independent passive force (Fpassive), 
and Ca2+-sensitivity of force production were determined 
in single, mechanically isolated, permeabilized cardiomyo-
cytes. Stress- and ovariectomy-induced alterations in myo-
filament proteins (myosin-binding protein C [MyBP-C], tro-
ponin I [TnI], and titin) were analyzed by sodium dodecyl 
sulfate gel electrophoresis using protein and phosphopro-
tein stainings.
Results Serum progesterone levels were significantly in-
creased in stressed rats (control-S, 35.6 ± 4.8 ng/mL and 
OVX-S, 21.9 ± 4.0 ng/mL) compared to control (10 ± 2.9 
ng/mL) and OVX (2.8 ± 0.5 ng/mL) groups. Factive was high-
er in the OVX groups (OVX, 25.9 ± 3.4 kN/m2 and OVX-S, 
26.3 ± 3.0 kN/m2) than in control groups (control, 16.4 ± 1.2 
kN/m2 and control-S, 14.4 ± 0.9 kN/m2). Regarding the 
potential molecular mechanisms, Factive correlated with 
MyBP-C phosphorylation, while myofilament Ca2+-sensi-
tivity inversely correlated with serum progesterone levels 
when the mean values were plotted for all animal groups. 
Fpassive was unaffected by any treatment.
Conclusion Stress increases ovary-independent synthesis 
and release of progesterone, which may regulate Ca2+-sen-
sitivity of force production in left ventricular cardiomyo-
cytes. Stress and female hormones differently alter Ca2+-
dependent cardiomyocyte contractile force production, 
which may have pathophysiological importance during 
stress conditions affecting postmenopausal women.
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The relation between stress, gender, and cardiovascular dis-
eases is well established (1-4). Some of the known risk fac-
tors for cardiovascular disease such as smoking, unhealthy 
diet, and behavioral and psychosocial stress have deleteri-
ous effects on the cardiovascular system via activation of 
the sympathetic nervous system and the hypothalamic-
pituitary-adrenal (HPA) axis (5-8). Acute restraint stress is 
a preferred and widely used method to induce physical 
stress in animal models (9). Moreover, restraint and immo-
bilization are important as models for psychological stress 
shown to adversely affect ovarian function (10) and play a 
pivotal role in the pathomechmanism of Takotsubo (stress) 
cardiomyopathy in postmenopausal women (11).
Gender is a very important factor in the development of 
cardiovascular diseases. Premenopausal women have bet-
ter lipid profile, endothelial function (12), and a lower risk 
to develop coronary artery disease and myocardial infarc-
tion (MI) than men. These advantages of female gender, 
however, are abolished after menopause, which is associ-
ated with increased prevalence of left ventricular (LV) hy-
pertrophy, decreased LV ejection fraction and LV contractil-
ity (13). One of the explanations for the distinct myocardial 
responses is the cardioprotective effect of female sex hor-
mones (eg, estrogens) (14,15).
Progesterone performs several actions on the heart: it ex-
erts an antiarrhythmic effect by accelerating cardiac repo-
larization (16) and has a preventive role in ischemia-rep-
erfusion injury via reducing inflammatory response (17). It 
has been shown to inhibit cardiomyocyte apoptosis (18), 
induce vasodilation, and reduce blood pressure via increas-
ing nitric oxide (NO) levels in normotensive and hyperten-
sive patients (19). Importantly, progesterone is produced 
by both the ovaries and the adrenal gland. Moreover the 
adrenal progesterone content is similar or even larger than 
that in the ovaries (20). Adrenal progesterone production 
and secretion increase along with corticosterone regard-
less of gender and estradiol under stress conditions (21). 
Progesterone, being an indirect precursor of cortisol (22), 
increases in response to adrenocorticotrophic hormone 
(ACTH) stimulation (23).
In the heart, there are multiple estrogen hormone receptor 
types (24). The expression of aromatase in the heart sug-
gests that estrogen may be synthesized also within the 
cardiomyocyte to exert autocrine/paracrine actions (25). 
Myocyte contractility seems to be modulated by sys-
temic estrogen levels and altered in cardiomyocytes 
derived from ovariectomized (OVX) rats (26). In par-
ticular, myofilament Ca2+-sensitivity is increased in isolated 
myofibrillar preparations from OVX rats, and restored to the 
basal levels with estrogen supplementation (27,28).
Activation of the sympathetic nervous system plays a cen-
tral role in the regulation of cardiomyocyte contractile 
function and myofilament Ca2+-sensitivity through beta-
adrenergic receptor stimulation, activating the protein ki-
nase A (PKA). PKA-mediated phosphorylation of Ca2+-han-
dling and myofilament proteins (myosin binding protein-C 
[MyBP-C], troponin I [TnI], titin) were shown to alter car-
diomyocyte contractile function (29,30). It has been sug-
gested that female cardiomyocytes operate at lower levels 
of intracellular Ca2+ than those of males, particularly under 
inotropic conditions (31). This difference in Ca2+ homeosta-
sis may be related to the fact that estrogen suppresses the 
L-type Ca2+ current (32,33) and may reduce the amount of 
Ca2+ released from the sarcoplasmic reticulum (SR) (34), 
which was shown to be larger in myocytes from OVX rats 
(35). Not only cardiomyocyte contraction, but relaxation 
may also be affected by estrogen via altered Ca2+ re-up-
take into the SR and modified Ca2+ efflux via increased sar-
colemmal Na+/Ca2+ exchange (36). Interestingly, despite 
similar SR Ca2+ content in males and females (37), stud-
ies using OVX models report conflicting results concern-
ing changes in the expression and activity of the SR Ca2+-
ATPase and its regulator protein phospholamban (38-41). 
Much less is known about the possible effect of progester-
one on cardiomyocyte contractile function. We hypothe-
sized that progesterone affected force production of single 
isolated cardiomyocytes. Therefore, in the present study 
we aimed to investigate how sex hormones (particularly 
progesterone) and single acute restraint stress altered car-
diomyocyte contractile function and attempted to iden-
tify the consequent posttranslational myofilament protein 
modifications in OVX rats.
METHodS
Animals
The study was conducted using female Sprague-Daw-
ley rats (n = 32) at the Department of Medical Biology of 
J. J. Strossmayer University of Osijek, School of Medicine 
(Osijek, Croatia) between June and September of 2013. 
Sixteen rats were ovariectomized at the age of 12 weeks. 
The ovariectomy was performed according to the proto-
col HUS-QREC-PRD-932 (Issue: 01, Revision 03). The anes-
thetized rat was placed in ventral recumbency with tail 
toward the surgeon. Following shaving and swabbing of 
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the dorsal mid-lumbar area, a 2-3 cm dorsal midline skin 
incision was made halfway between the caudal edge of 
the ribcage and the base of the tail. Thereafter, a single 
incision 5.5-10 mm long was made into the muscle wall 
on both the right and left sides, and the ovaries and the 
oviducts were exteriorized through the muscle wall. A he-
mostat was clamped around the uterine vasculature be-
tween the oviduct and uterus. Each ovary and part of the 
oviduct was removed with single cuts through the ovi-
ducts near the ovary. The remaining tissue was replaced 
into the peritoneal cavity. The muscle incision was not su-
tured. Age-matched not operated female Sprague-Dawley 
rats served as controls (n = 16). Animals were housed in 
standard cages at room temperature with natural day and 
night exchange. Standard laboratory food and tap water 
were available ad libitum. At the age of 28 weeks, 8 control 
and 8 OVX rats were submitted to cold restraint stress: rats 
were placed and closed in a metal tube with a diameter 
that did not allow them to move or turn around. The ani-
mals were kept under these conditions in a cold room at 
+4˚C for 1 hour (control-S and OVX-S groups). Immediately 
after the stress, the rats were anesthetized using combined 
inhalation of isoflurane (Forane®, Abbott Laboratories Ltd, 
Queenborough, United Kingdom) in a glass chamber and 
intramuscular administration of ketamine (Ketanest®S, Pfiz-
er Corporation, Wien, Austria, 30 mg/kg body weight) and 
then sacrificed. Blood was drawn from the heart for plas-
ma measurements. Thereafter, the left ventricles were cut 
and placed immediately into liquid nitrogen and stored 
at -80°C. The study protocol was approved by the Ethics 
Committee of the Osijek University School of Medicine. 
The heart tissue samples were transferred according to the 
regulations stated in the official material transfer agree-
ment between the School of Medicine Osijek and the Uni-
versity of Debrecen (DETTI/22-3/2013).
determination of serum estrogen and progesterone 
levels
Estradiol was measured using a chemiluminescent im-
munoassay (Roche Diagnostics GmbH, Mannheim, Ger-
many) by a specific polyclonal antibody against estradiol. 
The endogenous estradiol is released from the serum by 
mesterolone, which competes for the binding sites located 
on the biotinylated antibodies with estradiol derivative la-
beled with rutenium complex. The inter-assay coefficient 
of variation (CV) was <7% (lower detection limit: 4.9 pg/
mL, upper detection limit: 4.3 ng/mL). Progesterone was 
measured by a chemiluminescent immunoassay (Roche 
Diagnostics GmbH) using a specific monoclonal antibody 
against progesterone. The endogenous progesterone is re-
leased from the serum by danazol, which competes for the 
binding sites located on the biotinylated antibodies with 
progesterone derivative labeled with rutenium complex. 
The inter-assay CV was <5% (lower detection limit: 29.9 
pg/mL, upper detection limit: 60.1 ng/mL). Serum glucose 
concentration was measured by an enzymatic, photomet-
ric method (Roche Diagnostics GmbH). As a first step, glu-
cose-6-phosphate is formed from glucose and adenosine 
triphosphate catalyzed by hexokinase. In the presence of 
nicotinamide adenine dinucleotide phosphate (NADP) 
the glucose-6-phosphate is oxidized to gluconate-6-phos-
phate. The rate of formation of NADPH correlates with the 
glucose concentration and can be measured using pho-
tometry. Serum cholesterol was determined by an enzy-
matic, colorimetric method (Roche Diagnostics GmbH). 
Formation of H
2O2 – generated during the oxidation of the 
cholesterol by cholesterol oxidase – leads to the genera-
tion of red quinoneimine stain from 4-aminophenazone 
and phenol. The intensity of this red stain correlates with 
the concentration of cholesterol.
Measurement of cardiomyocyte mechanical parameters
Force measurements were performed in single, isolated 
cardiomyocytes derived from left ventricular (LV) rat myo-
cardium, as described previously (42). Briefly, samples were 
first defrosted in isolating solution (containing 100 mM KCl, 
2 mM EGTA, 1 mM MgCl2, 4 mM Na2ATP, 10 mM imidazol; 40 
µM leupeptin, 10 µM E64, pH 7.0), then mechanically dis-
rupted and treated with isolating solution supplemented 
with 0.5% Triton-X-100 to solubilize the membranes and 
membrane-associated structures. Thereafter, single car-
diomyocytes were mounted between a force transducer 
and an electromagnetic motor with silicone adhesive. Sar-
comere length was adjusted to 2.3 µm. Relaxing (contain-
ing 37.11 mM KCl, 10 mM BES, 6.41 mM MgCl2, 7 mM EGTA, 
6.94 mM Na2ATP, 15 mM Na2CrP, 40 µM leupeptin, 10 µM 
E64; pH 7.2) and activating (containing 37.34 mM KCl, 10 
mM BES, 6.24 mM MgCl2, 7 mM CaEGTA, 6.99 mM Na2ATP, 
15 mM Na2CrP, 40 µM leupeptin, 10 µM E64; pH 7.2) so-
lutions were used during force measurements with a pCa 
(ie, -10log[Ca
2+]) value of 10 and 4.5, respectively. Solutions 
with intermediate Ca2+ concentrations were prepared by 
mixing activating and relaxing solutions. Cardiomyocyte 
active force (Factive) and calcium sensitivity of force produc-
tion (characterized by pCa50) were determined by activa-
tions in solutions with different Ca2+ concentrations. Car-
diomyocyte passive force (Fpassive) was measured in the 
relaxing solution.
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determination of myofilament protein 
phosphorylation
A LV myocardial tissue sample (20 mg) was first handled 
similarly as for cardiomyocyte isolation, then homogenized 
in a sample buffer (containing 8 M urea, 2 M thiourea, 3% 
sodium dodecyl sulfate [SDS], 75 mM DTT, 0.05 M Tris-HCl 
[pH 6.8], 40 µM leupeptin, 10 µM E64, 10% glycerol, brome-
phenol blue). After centrifugation (16 000 g for 5 minutes) 
protein concentration was measured from the supernatant 
with a dot-blot based method, where different dilutions 
from bovine serum albumine served as standard. Protein 
concentration of the samples was adjusted to 1 mg/mL. 
Polyacrylamide gels (2% and 4%, agarose-strengthened 
or 15%) were used to separate titin, MyBP-C, and TnI, re-
spectively. Phosphorylation status of myofilament proteins 
was assessed by Pro-Q® Diamond phosphoprotein stain-
ing (Invitrogen, Eugene, OR, USA), while protein composi-
tion was visualized by Coomassie blue (Reanal, Budapest, 
Hungary). Separation and identification of myofilament 
proteins were carried out based on their molecular weight 
and compared to those of a molecular weight standard 
(marker 4.6 kDa – 300 kDa).
data analysis and statistics
Factive and Fpassive values were normalized to cardiomyocyte 
cross-sectional area and expressed in kN/m2. Calcium-
force relationship was fitted by a modified Hill equation 
(42). Intensities of the protein bands were quantified by 
densitometry using the ImageJ 1.41o (NIH, Bethesda, MD, 
USA) and Magic Plot Student 2.5.1 (Saint Petersburg, Rus-
sia) softwares. Phosphorylation of myofilament proteins 
was normalized to the protein amount and expressed in 
percentages relative to an internal control (same LV rat 
sample on each gel). Statistical significance was calculat-
ed by analysis of variance (ANOVA followed by Bonferro-
ni’s post hoc test) and linear regression. GraphPad Prism 
5.0 (GraphPad Software Inc., San Diego, CA, USA) soft-
ware was used. Values are given as mean ± standard er-
ror of the mean (SEM). The level of statistical significance 
was P < 0.05.
RESulTS
Effects of ovariectomy and stress on basic parameters
Basic physical and laboratory parameters measured in 
the four animal groups are listed in Table 1. Both body 
weight and heart weight were significantly higher in the 
OVX-S group than in the control group, but heart-to-
body weight ratios did not significantly differ. Serum bas-
al glucose and total cholesterol levels were the same in all 
groups. Other relevant physiological parameters, such as 
heart rate and arterial blood pressure, were not assessed 
in this study.
TABlE 1. Basic physical and laboratory parameters measured in control, stressed control (control-S), ovariectomized (oVX), and 
stressed oVX (oVX-S) animals. data are presented as mean ± standard error of the mean
Control Control-S oVX oVX-S P value
Body weight (g) 288.4 ± 4.7 286.6 ± 2.4 297.8 ± 3.9 328.6 ± 5.8*†‡ <0.001
Heart weight (g)   1.1 ± 0.05   1.1 ± 0.03   1.2 ± 0.04   1.3 ± 0.04* <0.050
Heart-to-body weight ratio    0.004 ± 0.0002   0.004 ± 0.0001   0.004 ± 0.0001   0.004 ± 0.0002   N.S.
Progesterone (ng/mL)  10 ± 2.9  35.6 ± 4.8*   2.8 ± 0.5  21.9 ± 4.0‡ <0.001*; <0.01‡
Glucose (mmol/L)  11.8 ± 0.9   9.7 ± 0.7   9.9 ± 0.4  10.3 ± 0.7   N.S.
Cholesterol (mmol/L)   2.4 ± 0.1   2.6 ± 0.3   2.5 ± 0.1   2.6 ± 0.1   N.S.
*Significant difference vs control.
†Significant difference vs control-S.
‡Significant difference vs oVX.
FiGuRE 1. Serum progesterone levels measured using a 
chemiluminescent immunoassay in control and ovariecto-
mized (oVX) rats not exposed and exposed to stress (control 
and oVX vs control-S and oVX-S, n = 8 for all groups). Bars are 
mean ± standard error of the mean and significant differences 
(P < 0.05) are denoted by asterisks.
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Effects of ovariectomy and stress on serum estrogen 
and progesterone levels
Female sex hormones were measured from the sera of 
control and OVX animals. No measurable estrogen levels 
(detection limit was 4.9 pg/mL) were present in all OVX 
samples, indicating successful ovariectomy. Some of the 
control animals had measurable estrogen levels (about 
25%), which was in accordance with the phases in the 
animal’s estrus cycle (data not shown). Progesterone lev-
els were above the lower detection limit in all animal 
groups and were significantly increased in stressed con-
trol (35.6 ± 4.8 ng/mL) and stressed OVX (21.9 ± 4.0 ng/
mL) rats compared to non-stressed control (10 ± 2.9 ng/
mL) and OVX (2.8 ± 0.5 ng/mL) groups (n = 8 rats/group, 
P < 0.001 control-S vs control; P < 0.010 OVX-S vs OVX, Fig-
ure 1). The increase in progesterone levels during stress 
was comparable in control-S (25.6 ng/mL) and OVX-S 
(19.1 ng/mL) rats.
ovariectomy alters cardiomyocyte contractile function
Factive, Fpassive, and calcium sensitivity of force production 
(pCa50) were determined in cardiomyocytes isolated from 
LV myocardium of rats at a sarcomere length of 2.3 µm 
(n = 10 cardiomyocytes per group) (Figure 2A). Factive was 
significantly higher in OVX and OVX-S animals than in con-
trol and control-S rats (25.9 ± 3.4 kN/m2 and 26.3 ± 3.0 kN/
m2 vs 16.4 ± 1.2 kN/m2 and 14.4 ± 0.9 kN/m2, respectively, 
P < 0.050). However, no change in Factive was observed in 
control and OVX animals upon stress (Figure 2B). No signif-
icant differences in pCa50 were found between control and 
OVX animals, although a trend toward lower pCa50 was ob-
served in control-S and OVX-S cardiomyocytes (Figure 2C). 
FiGuRE 2. Effects of ovariectomy and stress on cardiomyocyte mechanics. (A) Single cardiomyocyte, isolated from rat myocardium, 
mounted between a sensitive force transducer and an electromagnetic motor (upper panel). Measurements of maximum (pCa [ie, 
-10log[Ca
2+]] 4.75) Ca2+-dependent active (Factive) and Ca
2+-independent (pCa 10) passive (Fpassive) force levels in control and ovariec-
tomized (oVX) animals (lower panel). (B) Effect of ovariectomy (oVX) and stress (control-S and oVX-S) on cardiomyocyte Factive 
(*P < 0.050 vs control). (C) Calcium sensitivity of force production (pCa50) determined in skinned cardiomyocytes derived from lV 
tissue in the four animal groups. (D) unaltered Fpassive by ovariectomy or stress (number of cardiomyocytes, n = 10 per group of 5-7 
animals).
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Neither ovariectomy nor stress altered Fpassive in all groups 
(Figure 2D). There were no changes in cardiomyocyte 
structure after ovariectomy or stress (data not shown).
Changes in myofilament protein composition and 
phosphorylation upon ovariectomy and stress
Myofilament protein composition was studied by SDS gel 
electrophoresis followed by quantitative protein staining. 
No considerable differences were detected in myocardial 
protein composition between control and OVX animals 
(Figure 3A). Using Pro-Q® Diamond phosphoprotein stain-
ing, a significant increase in relative total TnI phosphory-
lation was observed in OVX animals compared to con-
trols (153 ± 14.4% vs 98.5 ± 4%, P < 0.001). The increased 
TnI phosphorylation in OVX animals was not accompa-
nied by a decrease in the pCa50 measured in the cardio-
myocytes (r = 0.268, P = 0.732). Phosphorylation of TnI in 
OVX-S rats (113.1 ± 3.6%) was similar to the values mea-
sured in control and control-S animals (Figure 3B). Phos-
phorylation of MyBP-C was significantly higher in OVX rats 
than in controls (167.7 ± 7% vs 131.4 ± 5.5%, P < 0.001), but 
it remained unchanged under stress conditions in OVX-S 
rats (182.9 ± 6.2%, Figure 3C). In accordance with the un-
changed Fpassive, phosphorylation of titin was the same in 
the four groups (Figure 3D).
Correlation of cardiomyocyte function with 
myofilament phosphorylation and sex hormone levels
When phosphorylation of myofilament proteins and cardi-
omyocyte functional parameters were correlated, a strong 
positive correlation was observed between cardiomyocyte 
Factive and MyBP-C phosphorylation (r = 0.986, P < 0.050, Fig-
FiGuRE 3. Representative examples of myofilament protein composition and protein phosphorylation in the left ventricular (lV) 
myocardium from control and ovariectomized (oVX) rats. (A) Myofilament protein composition in lV tissue homogenate in control – 
1, stressed control (control-S) – 2, ovariectomized (oVX) – 3, and stressed-oVX (oVX-S) animals – 4 (Coomassie blue protein staining, 
MHC – myosin heavy chain). (B) increased overall troponin i phosphorylation (P-Tni) in oVX, but not in oVX-S group (*P < 0.05 vs con-
trol). (C) Elevated myosin binding protein-C phosphorylation (P-MyBP-C) in oVX and oVX-S rats (*P < 0.05 vs control). (D) Similar titin 
phosphorylation (P-titin) in the four experimental groups (Phosphorylation of myofilament proteins was normalized to the protein 
amount and expressed in percentages relative to an internal control).
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ure 4A). Titin phosphorylation did not correlate with car-
diomyocyte Fpassive (r = 0.139, P = 0.861). Serum progester-
one levels and pCa50 of the cardiomyocytes measured in 
the same animals showed a significant inverse correlation 
(r = 0.963, P < 0.050, Figure 4B).
diSCuSSion
Several studies reported divergent effects of stress and fe-
male sex hormones on the cardiovascular system, howev-
er, their effect on cardiomyocyte contractile function is not 
fully elucidated. Our study showed that: I. serum progester-
one levels were more than three times higher in control-S 
and OVX-S rats than in control and OVX animals; II. Factive of 
cardiomyocytes was significantly higher in OVX rats than in 
controls; III. Fpassive and pCa50 was similar in OVX and control 
animals, although a moderate trend to lower pCa50 values 
was observed in control-S and OVX-S rats; IV. progesterone 
levels inversely correlated with pCa50 of cardiomyocytes; V. 
no major differences in myofilament protein composition 
were observed among the four groups, however, overall 
phosphorylation of TnI and MyBP-C was significantly high-
er in the OVX group than in controls.
Many studies showed that serum progesterone level in-
creased under stress conditions due to its secretion from 
the adrenal cortex (20,21,23,43). In accordance with other 
findings (21), in the present study ovariectomy did not al-
ter the amount of progesterone secreted during stress and 
the progesterone response under stress conditions.
Progesterone, as an intermediate product in the synthesis 
of cortisol, also has a crucial role in stress response (44) and 
in the regulation of the HPA axis (43). However, it is also 
important to note that acute and chronic stress have dif-
ferent effects on the activation of the sympathetic nervous 
system and HPA axis. Acute cold restraint stress applied in 
the present study has been shown to increase ACTH, and 
corticosterone levels followed a desensitization of the HPA 
response to increase stroke volume and decrease the heart 
rate (45). Based on the presence of progesterone recep-
tors within the myocardium (46), changes in progesterone 
levels could alter cardiomyocyte contractile properties. In-
deed, the present study confirmed a significant correlation 
between serum progesterone levels and pCa50 of cardio-
myocytes. This may indicate that the moderate decrease in 
pCa50 observed in control-S and OVX-S animals may be re-
lated to the increased progesterone levels. The inverse cor-
relation between serum progesterone levels and myofila-
ment Ca2+-sensitivity may provide a potential explanation 
for lowered cardiovascular risk in fertile women.
Experimental evidence confirms that ovariectomy induc-
es up-regulation of cardiac β1-adrenergic receptor (β1-AR) 
expression, which can be prevented by estrogen and/or 
progesterone administration (47). β1-AR is a major regula-
tor in the cardiac function and its activation increases heart 
rate and myocardial contractility (48). It was also found that 
ovariectomy increases the amplitude of the basal and iso-
prenaline-induced contractions, and induces an increase 
in β1-AR and a decrease in β2-AR expression (49). Stimula-
tion of β1-AR activates Gs protein, leading to an increase 
in cAMP concentration. cAMP activates PKA, which phos-
phorylates myocardial proteins such as MyBP-C (50). 
Phosphorylation of MyBP-C accelerates cross-bridge 
kinetics (51) and increases calcium-activated maxi-
FiGuRE 4. Correlations between myofilament phosphorylation, sex hormones, and cardiomyocyte function. (A) Strong correlation 
between myosin-binding protein C (MyBP-C) phosphorylation and cardiomyocyte Factive (r = 0.986, P < 0.05). (B) Calcium sensitivity of 
force production (pCa50) inversely correlated with serum progesterone levels (r = 0.963, P < 0.05). Correlation was assessed by fitting 
the values by a linear regression.
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mal force production (52). In accordance with this obser-
vation, our study also revealed a significant increase in 
cardiomyocyte Factive in OVX rats. Moreover, phosphoryla-
tion of MyBP-C correlated with cardiomyocyte Factive. Be-
sides MyBP-C phosphorylation, changes in the distribution 
of the two myosin heavy chain (MHC) isoforms are also 
shown to be involved in the regulation of active force pro-
duction (53). Due to limitations of myocardial tissue sam-
ples, in the present investigation we could not address this 
issue. Based on our findings, the increased Factive can be ex-
plained by the elevated phosphorylation of MyBP-C due 
to an increased β1-adrenerg stimulation after ovariectomy. 
This may indicate that the physiological regulatory effect 
of MyBP-C phosphorylation on cardiomyocyte active force 
generation is preserved after ovariectomy and stress.
Besides MyBP-C, phosphorylation of TnI and titin by PKA 
also alters cardiomyocyte contractile function, resulting in 
a decrease in pCa50 (29) and Fpassive (54). In this study no ma-
jor differences were found in pCa50 among the groups (only 
a moderate, non-significant decrease was observed in the 
control-S and OVX-S groups). Total phosphorylation of TnI, 
however, was increased in the OVX group, but this was not 
accompanied by a decrease in pCa50. This could result from 
the lack of specificity of the phosphoprotein staining for 
the different phosphorylation sites of the proteins. There-
fore, despite the significant increase in total TnI phospho-
rylation, differences in the phosphorylation of the protein 
kinase-specific sites (PKA, PKC-βII, δ, ε) – which have been 
shown to have divergent effects on pCa50 (55) – cannot be 
excluded. A modulating effect of ovarian sex hormone de-
ficiency on Ca2+-responsiveness of myofilament activation 
was demonstrated convincingly in the study by Wattana-
permpool (27). In that study, an increase in the myofila-
ment pCa50 and a decrease in the maximum myofibrillar 
ATPase activity was found in eight-week OVX rats at pH 7.0, 
together with an unchanged maximum ATPase activity 
and no differences in pCa50 at pH 6.5. However, when the 
study was extended to ten-week OVX rats, parallel to the 
suppression of maximum ATPase activities, a significant hy-
persensitivity of myofilaments to Ca2+ could also be detect-
ed at both pH 7.0 and pH 6.5 in the OVX group. This finding 
underlies the importance of the time and the progressive 
nature of myofilament alterations after ovariectomy. We 
did not detect significant difference in the myofilament 
Ca2+-sensitivity between control and OVX rats. 
In the present study, no correlation between cardiomyo-
cyte Fpassive and phosphorylation of its main regulator 
sarcomeric protein, titin was observed. This finding is 
consistent with an earlier report demonstrating unchanged 
passive stiffness in OVX animals (56). No differences were 
found in the phosphorylation of myofilament proteins be-
tween the control and control-S groups. The basal level of 
PKA-dependent protein phosphorylation in rodent hearts 
appears to be significantly higher than in large mammals 
(57). Accordingly, relative changes in the level of PKA-de-
pendent protein phosphorylation under acute stress con-
ditions and/or in vitro PKA challenges can be smaller in the 
hearts of small rodents than in large mammals. Moreover, 
sympathetic effects of acute stress tend to rapidly desensi-
tize. Taking all this into consideration, we hypothesize that 
the combination of the above characteristics explains the 
unchanged phosphorylation level of myofilament proteins 
in control-S compared to control group.
Stress procedures used in this study induced physiologi-
cal alterations and pathophysiological changes. However, 
the effects of this particular stress input (immobilization in 
combination with cold) may be unlikely in everyday hu-
man life. Further studies are necessary to confirm that the 
observed effects could be generalized for other types of 
acute stress.
Control animals were not sham-operated. Operation itself 
may have contributed to the differences between control 
and OVX groups. In future studies, sham-operated animals 
have to be used as controls. Type of anesthetics, in particu-
lar, application of isoflurane may have affected myocardial 
parameters (58). Also, the levels of estrogen and proges-
terone were low, considerably below the lower detection 
limit of the applied technique.
The present study assessed contractile properties of sin-
gle, demembranated cardiomyocytes and focused mainly 
on alterations in the composition and phosphorylation of 
myofilament proteins. Changes in sarcolemmal, sarcoplas-
mic, and Ca2+-handling proteins cannot be studied under 
such experimental conditions as a result of the membrane 
solubilisation. Single cardiomyocytes may not represent 
overall myocardial function. Moreover, heart samples were 
frozen and their functional and biochemical properties 
were evaluated upon thawing. Nevertheless, this approach 
was supported by our previous experience, when we did 
not find significant effects of freezing and thawing on the 
functional properties of cardiomyocyte preparations inde-
pendently of the species (30,59).
Single acute stress significantly increased serum progester-
one levels in both control and OVX rats. Stress and female 
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hormones altered cardiomyocyte contractile force genera-
tion possibly by increasing Ca2+-activated force production 
through myosin-binding protein C phosphorylation. The 
observed functional changes and myofilament modifica-
tions may contribute to the lower cardiovascular risk in fer-
tile women.
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